BALDO LANCE

CIK 00017807731 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001780773

Recent Transactions

50 trades

Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-08$11.43/sh−3,350→ 17,171 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-07$12.01/sh−2,373→ 20,521 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-04-14$7.80/sh+2,000→ 24,894 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-04-14−2,000→ 339,250 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-04-14$44.50/sh−2,000→ 22,894 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-03-04+57,234→ 57,234 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-03-04+22,894→ 22,894 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-01-27$7.80/sh+40,000→ 40,000 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-01-27$58.22/sh−17,499→ 22,501 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-01-27$60.01/sh−8,268→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-01-27−40,000→ 341,250 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-01-27$59.24/sh−14,233→ 8,268 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-12-07$7.80/sh+6,250→ 6,250 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-12-07$51.26/sh−2,470→ 0 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-12-07$50.14/sh−3,000→ 2,470 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-12-07$48.79/sh−780→ 5,470 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2020-12-07−6,250→ 381,250 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-11-06$51.26/sh−797→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2020-11-06−6,250→ 387,500 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-11-06$7.80/sh+6,250→ 6,250 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-11-06$50.54/sh−5,453→ 797 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-10-06$7.80/sh+6,250→ 6,250 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-10-06$48.90/sh−4,236→ 2,014 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2020-10-06−6,250→ 393,750 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-10-06$49.84/sh−2,014→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2020-09-29−25,000→ 400,000 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-09-29$7.80/sh+25,000→ 25,000 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-09-29$50.00/sh−25,000→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2020-09-11−4,149→ 425,000 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-09-11$40.00/sh−4,149→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-09-11$7.80/sh+4,149→ 4,149 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-09-10$7.80/sh+18→ 18 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2020-09-10−18→ 429,149 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-09-10$40.00/sh−18→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2020-09-08−2,083→ 429,167 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-09-08$7.80/sh+2,083→ 2,083 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-09-08$36.17/sh−2,083→ 0 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-08-06$40.00/sh−6,250→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-08-06$7.80/sh+6,250→ 6,250 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2020-08-06−6,250→ 431,250 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-07-06$7.80/sh+6,250→ 6,250 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-07-06$48.42/sh−200→ 0 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-07-06$47.29/sh−6,050→ 200 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2020-07-06−6,250→ 437,500 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-06-09$7.80/sh+4,167→ 4,167 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-06-09$40.00/sh−4,167→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2020-06-09−4,167→ 443,750 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2020-06-08−2,083→ 447,917 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-06-08$38.99/sh−1,963→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-06-08$7.80/sh+2,083→ 2,083 total

Companies

Adaptive Biotechnologies Corp
Chief Medical Officer
$ADPT

Recent Filings

Address

C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1551 EASTLAKE AVE E STE 200

SEATTLE, WA, 98102

View on SEC.gov